Blood-Based Biomarkers in Prostate Cancer
Blood-based biomarkers refine prostate biopsy decisions beyond PSA alone. Dr. Brant Inman reviews commonly used serum tests.
Read More
Select Page
Brant A. Inman, MD, MS, FRCSC, is Chin-Hardie Chair of Urologic Oncology and Professor of Urology and Oncology at Western University in London, Canada. Dr. Inman’s clinical specialties include cancers of the prostate, bladder, kidney, ureter and renal pelvis, testis, adrenal, penis, and sarcomas. He has a particular interest in inherited genetic syndromes that cause urological cancers and in complex cancers that require multi-disciplinary care. Dr. Inman performs surgery using a wide variety of methods including laparoscopic and robotic minimally invasive surgery, endoscopic surgery, and open surgery.
Dr. Inman earned his Bachelor of Medical Science and MD from the University of Alberta in Edmonton, Canada. He then completed a residency in Urology at l’Université Laval in Québec City, Canada. Dr. Inman subsequently completed a fellowship in Urologic Oncology and earned his Master’s in Clinical and Translational Research at the Mayo Clinic in Rochester, Minnesota.
Dr. Inman has served as a researcher for several projects including the development of new diagnostic tests for cancer, the development and testing of new treatments for cancer, understanding the immune response to cancer, and describing the genetic underpinnings of cancer. His research interests are in the field of urologic oncology, including clinical trials and translational research related to bladder, prostate, and kidney cancer. Dr. Inman has authored and co-authored over 240 publications in his field. He has been a member of Board of Directors of the Society of Urologic Oncology Clinical Trials Consortium, a member of the National Comprehensive Cancer Network bladder and penile cancer panel, a member of the Research Council and Research Grants and Investigator Support Committee of the American Urological Association, and a member of the Urological Research Society.
Brant A. Inman, MD, MS, FRCSC | Jan 2026
Blood-based biomarkers refine prostate biopsy decisions beyond PSA alone. Dr. Brant Inman reviews commonly used serum tests.
Read More